维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="ABKEN H"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	B7-1 and B7-2 act differentially in the induction of a T cell response: their impact for a HLA-matehed and HLA-mismatehed anti-tumor immunotherapy 显示文摘	Krenfeld K Abken H seliger B	2005	Int J Cancer2005，117，5：	1
2	The weal and woe of costimula- tion in the adoptive therapy of cancer with chimeric antigen receptor ( CAR) -redirected T cells显示文摘	Hombach AA Holzinger A Abken H	2013	Curr Mol Med2013，13，7：	1
3	HLA-G and MIC expression in tumors and their role in anti-tumor immunity显示文摘	Seliger B Abken H Ferrone S	2003	Trends Immunol2003，24，2：	1
4	CAR T cells transform to trucks:Chim- eric antigen receptor- redirected T cells engineered to deliver in- ducible IL - 12 modulate the tumour stroma to combat cancer显示文摘	Chmielewski M Abken H	2012	Cancer Immunol Immun2012，61，8：	1
5	TRUCKs: the fourth generation of CARs显示文摘	Chmieleski M Abken H		Expert Opin Biol Ther0，15，8：	1
6	The weal and woe of co- stimulation in the adoptive therapy of cancer with chimeric an- tigen receptor (CAR) -redirected T cells 显示文摘	Hombach AA Holzinger A Abken H	2013	Curt' Mol Med2013，13，7：	1
7	CD4 + CD7- leukemic T cells from patients with S6zary syndrome are protected from galectin-1- triggered T cell death 显示文摘	Rappl G Abken H Muche JM	2002	Leukemia2002，16，5：	1
8	Can combined cell and anbody-based immunotherapy outsmart tumor cell 显示文摘	Abken H Hombach A Reinhold U	1998	Immunol Today1998，19，1：	1
9	Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma显示文摘	Chmielewski M Hombach AA Abken H	2014	Immunol Rev2014，257，1：	1
10	HLA-G and MIC expression in tumors and their role in anti-tumor immunity 显示文摘	Sefiger B Abken H Ferrone S	2003	Trends Immunol2003，24，2：	1
11	Antibody-IL2 fusion proteins for tumor targeting显示文摘	Hombach AA Abken H	2012	Methods Mol Biol2012，907，：	1
12	Of CARs and TRUCKs: chimeric antigen receptor(CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma 显示文摘	Chmielewski M I-Iombach AA Abken H	2014	Immunol Rev2014，257，1：	1
13	Antibody-IL2 fusion proteins for tumor targeting显示文摘	Ombach AA Abken H	2012	Methods Mol Bio12012，907，：	1
14	Combining cytokine-induced killer cells with vaccination in cancer immunotherapy显示文摘	Thanendrarajan S Nowak M Abken H	2011	Leukemia Research2011，35，：	1
15	Immortali-zation of human lymphocytes by fusion with cytoplasts oftransformed mouse L cells 显示文摘	ABKEN H JUNGFERH ALBERT W H	1986	J Cell Biol1986，103，3：	1
16	CD4+CD7-leukemic T cells from patients with Sezary syndrome are protected from galectin-1 triggered T cell death显示文摘	Rappl G Abken H Muche JM	2002	Leukemia2002，16，5：	1
17	Improved activation toward primary colorectal cancer cells by antigenspecific targeting autologous cytokine-induced killer cells显示文摘	Schlimper C Hombach AA Abken H	2012	Clin Dev Immunol2012，23，8：	1
18	HLA-G and MIC expression in tumors and their role in anti-tumor immunity 显示文摘	Abken H Ferone S	2003	Trend Immunol2003，24，2：	1
19	Tumor-specific T cell activation by recombinant inmmnoreceptors: CD3 zeta signaling and CD28 costimulation are simuhaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule显示文摘	Hombach A Wieczarkowiecz A Marquardt T Heuser C Usai L Pohl C Seliger B Abken H	2001	J Immunol2001，167，11：	1
20	HLA-G and MIC expression in tumors and their role in anti-tumor immunity 显示文摘	Seliger B Abken H Ferrone S	2003	Trends Immunol2003，24，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示